Completed OBSERVATIONAL NCT02809989

A Study to Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen.

Multicentre, Prospective, Open, Non-interventional Study to Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen in the Clinical Routine of the IVF- / ICSI-treatment.

Sponsor: Teva Pharma GmbH

Conditions Oocytes Pregnancy Rate

Interventions Ovaleap®

Updated 14 times since 2017 Last updated: Nov 5, 2021 Started: Mar 31, 2016 Primary completion: Jul 21, 2017 Completion: Mar 13, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Oocytes and Pregnancy Rate and is currently completed. Teva Pharma GmbH leads this study, which shows 14 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

14 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed

▶ Show 9 earlier versions

Dec 2018 — Jan 2021 [monthly]

Completed

Status: Active Not Recruiting → Completed
Aug 2018 — Dec 2018 [monthly]

Active Not Recruiting
Jul 2018 — Aug 2018 [monthly]

Active Not Recruiting
Jun 2018 — Jul 2018 [monthly]

Active Not Recruiting
Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting

Phase: NA → None
Sep 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

Status: Enrolling By Invitation → Active Not Recruiting
May 2017 — Sep 2017 [monthly]

Enrolling By Invitation NA
Apr 2017 — May 2017 [monthly]

Enrolling By Invitation NA
Jan 2017 — Apr 2017 [monthly]

Enrolling By Invitation NA

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Teva Pharma GmbH

Data source: Teva Branded Pharmaceutical Products R&D, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalen, Germany , Berlin, Germany , Bielefeld, Germany , Dortmund, Germany , Düsseldorf, Germany , Essen, Germany , Esslingen am Neckar, Germany , Großhansdorf, Germany , Hamburg, Germany , Hanover, Germany and 17 more locations